Oral IBS-D medicine trial for kids and teens
Part of Digestive system clinical trials.
This trial tests whether an oral medicine (eluxadoline) can help children and teens with IBS-D, a condition that causes stomach pain and frequent loose stools. It’s a Phase 3 study, meaning it’s designed to confirm benefits and safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be age 6 to 17 (inclusive)
- You must have finished the earlier “lead-in” part of the study
- You cannot be allergic to opioids (or have had serious reactions)
- If you are female, you cannot be pregnant or nursing, and you must avoid pregnancy during the study
- You must have your gallbladder (no gallbladder removal and no known gallbladder absence)
- You must not have certain stomach/organ problems (like pancreatitis, biliary blockage, or opioid-risk digestive issues)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether eluxadoline can reduce symptoms of IBS with diarrhea (IBS-D) in children ages 6 to 17. It also asks families to track symptoms with a daily diary to measure whether treatment helps over the study period.
This study tests whether a specific diet plan can improve symptoms in people with IBS that is not constipation (IBS-D or IBS-M). If you qualify, you’ll complete symptom questionnaires and follow the study diet for the trial period to see if symptoms improve.
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
This trial tests an online social learning program to help parents support their child when the parent has irritable bowel syndrome (IBS) or related belly pain. It may help families build coping skills and resilience through guided parent sessions.
This trial tests a combination of digestive enzymes and probiotics (called Enzymax DuoBiotics) to see if it can help people with irritable bowel syndrome (IBS) feel better. If you have IBS and are between 18 and 70, this study may be a good fit.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.